Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Cited by (1,001)

Items 601–700 of 1,001

  1. Metabolic interventions: A new insight into the cancer immunotherapy
    Tao Yu, Tianhan Dong, Haniyeh Eyvani, Yuanzhang Fang, Xiyu Wang, Xinna Zhang, Xiongbin Lu · 2020 · Archives of Biochemistry and Biophysics
  2. Oxidation of Energy Substrates in Tissues of Fish: Metabolic Significance and Implications for Gene Expression and Carcinogenesis
    Sichao Jia, Xinyu Li, Wenliang He, Guoyao Wu · 2021 · Advances in experimental medicine and biology
  3. Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer
    Yinwei Dai, Zhi-kai Wen, Zhixuan Wu, Haodong Wu, Linxi Lv, Congzhi Yan, Conghui Liu, Zi-qiong Wang, Zheng Chen · 2022 · Frontiers in Genetics
  4. SLC38A6, regulated by EP300-mediated modifications of H3K27ac, promotes cell proliferation, glutamine metabolism and mitochondrial respiration in hepatocellular carcinoma
    Li Huang, Lixing Li, Bin Cheng, Tonghai Xing · 2022 · Carcinogenesis
  5. Differential glutamine metabolism in the tumor microenvironment – studies in diversity and heterogeneity: A mini-review
    Michael D. Claiborne, Robert D. Leone · 2022 · Frontiers in Oncology
  6. Immunometabolic Targets in CD8+ T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma
    Yanze Lin, Rexiati Ruze, Ruiqing Zhang, Talaiti Tuergan, Maolin Wang, Alimu Tulahong, Dalong Zhu, Zhongdian Yuan, Tiemin Jiang, Tuerganaili Aji et al. · 2024 · Liver Cancer
  7. The impact of metabolic reprogramming on tertiary lymphoid structure formation: enhancing cancer immunotherapy
    Meng-Jie Zhang, Yan Wen, Zhi‐Jun Sun · 2025 · BMC Medicine
  8. Tumor Microenvironment Metabolism‐Modulating Nanomedicines for Enhancing Anti‐Tumor Immunity
    Jiajie Chen, S. Fei, Zhihao Cao, Xinchun Liu, Weizhi Ji, Hangrong Chen, Yuyu Niu, Zebin Yang · 2025 · Small
  9. Metabolic networks in the tumor microenvironment: roles of amino acid and lipid metabolism pathways in cancer progression and therapy
    Yulseung Sung, Dae Kyoung Kim, Jun Se Kim, Seong-Jang Kim, Jae Ho Kim, Jung Min Han · 2026 · Experimental & Molecular Medicine
  10. Engineered Electrotherapy Platforms: Integrating Electroactive Materials for Precision Cancer Therapy
    Yichi Cai, Shumin Sun, Jihu Nie, Nailin Yang, Liang Cheng · 2026 · Advanced Materials
  11. Biodegradable self-assembly micelles significantly enhanced the solubility, biological stability and in vivo antitumor efficacy of Hexylselen
    Jinzhang Fang, Zhao Chen, Jun Song, Jinxiu Li, Yunying Han, Wei Hou, Wenxi Wang, Benfang Helen Ruan · 2021 · RSC Chemical Biology
  12. YTHDF1 in Tumor Cell Metabolism: An Updated Review
    Haichuan Rong, Danyang Wang, Yiran Wang, Chenshuang Dong, Guiling Wang · 2023 · Molecules
  13. Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy
    Brian S. Henick, Alison Marie Taylor, Hiroshi Nakagawa, Kwok‐Kin Wong, John Alan Diehl, Anil K. Rustgi · 2025 · Cancer Cell
  14. Metformin combined with CB-839 specifically inhibits KRAS-mutant ovarian cancer
    Han Wu, Jialin Zhang, Qiujie Wang, Zijiao Li, Linlin Li, Ya Xie · 2025 · Scientific Reports
  15. Discovery of novel glutaminase 1 allosteric inhibitor with 4-piperidinamine linker and aromatic heterocycles
    Xi Jin Xu, Xiujin Chang, Jingxuan Huang, Di Zhang, Min Wang, Tian Jing, Yu Zhuang, Junping Kou, Zhixia Qiu, Jubo Wang et al. · 2022 · European Journal of Medicinal Chemistry
  16. Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing
    Qianqian Xue, Wenbei Peng, Siyu Zhang, Xiao‐Shan Wei, Linlin Ye, Zihao Wang, Xuan Xiang, Pei Zhang, Qiong Zhou · 2023 · Frontiers in Immunology
  17. Modeling metabolic variation with single-cell expression data
    Yuanchao Zhang, Man Soo Kim, Elizabeth Nguyen, Deanne M. Taylor · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Dissecting L-glutamine metabolism in acute myeloid leukemia: single-cell insights and therapeutic implications
    Yanli Chen · 2024 · Journal of Translational Medicine
  19. Amino acid-based biomaterials for modulation of cell behaviors: from mechanisms to biomedical applications
    Mingyue Liu, Jinjin Chen, Hongjie Li, Yulong Ma, Qingyang Xiao, Jianxun Ding, Jinghong Li, Xuesi Chen · 2026 · Chemical Society Reviews
  20. From immune exclusion to exhaustion: tumor microenvironment drives therapy response
    Nemanja Maletin · 2026 · Frontiers in Immunology
  21. Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products
    Meghan T. Logun, Maxwell B. Colonna, Katherine P. Mueller, Divya Ventarapragada, Riley Rodier, Chaitanya Tondepu, Nicole J. Piscopo, Amritava Das, Stacie A. Chvatal, Heather Brant Hayes et al. · 2023 · Cytotherapy
  22. Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for Pancreatic Ductal Adenocarcinoma Treatment
    Yukun Huang, Yu Chen, Songlei Zhou, Laozhi Xie, Kaifan Liang, Jianpei Xu, Qian Zhang, Huan Chen, Dayuan Wang, Qingxiang Song et al. · 2023 · ACS Nano
  23. Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy
    Kenneth K.W. To, William Chi Shing Cho · 2023 · Pharmaceutics
  24. GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration
    Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao · 2024 · Cancer Immunology Immunotherapy
  25. Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo
    Rutulkumar Patel, Daniel E. Cooper, Kushal T. Kadakia, Annamarie E. Allen, Likun Duan, Lixia Luo, Nerissa T. Williams, Xiaojing Liu, Jason W. Locasale, David G. Kirsch · 2024 · Communications Biology
  26. Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma
    Gengrun Wu, Teng Li, Yuanbiao Chen, Shiqi Ye, Siqi Zhou, Xi Tian, Aihetaimujiang Anwaier, Shuxuan Zhu, Wenhao Xu, Xiaohang Hao et al. · 2024 · Clinical and Experimental Medicine
  27. Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and γ-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma
    Minchao Lv, Bin Liu, Yi Duan, Jiangtao Lin, Dai Li, Yuanyuan Li, Jian Yu, Jinghan Liao, Jiali Zhang, Yourong Duan · 2024 · ACS Nano
  28. Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
    Jinsheng Shi, Wei Han, Jie Wang, Xiaoying Kong · 2025 · Advanced Materials
  29. Polymer nanoparticles regulate macrophage repolarization for antitumor treatment
    Xuancheng Fu, Jiamu Yu, Anran Yuan, Libing Liu, Hao Zhao, Yiming Huang, Song Shen, Fengting Lv, Shu Wang · 2021 · Chemical Communications
  30. The critical function of metabolic reprogramming in cancer metastasis
    Sun‐Zhe Xie, Jun‐Jie Pan, Jianfeng Xu, Wenwei Zhu, Lun–Xiu Qin · 2022 · Aging and Cancer
  31. LCK senses asparagine for T cell activation
    Jana L. Raynor, Hongbo Chi · 2021 · Nature Cell Biology
  32. Targeting metabolism to influence aging
    Christopher C. Pan, Jason W. Locasale · 2021 · Science
  33. Targeting the crosstalk between glutamine metabolism and tumor immune microenvironment for lung cancer immunotherapy
    Jingyang Li, Xiang Li, Shaohui Wang, Yingrui Zhang, Shiyi Zhao, Di Zhang, Xianli Meng, Yi Zhang, Jin‐Ming Lin · 2025 · Interdisciplinary medicine
  34. Mitochondrial metabolism in cancer stem cells (CSCs): molecular and diagnostic implications
    Charan Psvv, Sona Sunil, Nandana Thuyyath, Rekha Rani Kokkanti, Kousalya Lavudi · 2026 · Frontiers in Molecular Biosciences
  35. Glutamine Inhibition Reduces Iatrogenic Laryngotracheal Stenosis
    Hsiu‐Wen Tsai, Ioan A. Lina, Kevin Motz, Liam Chung, Dacheng Ding, Michael K. Murphy, Michael Feeley, Jennifer H. Elisseeff, Alexander T. Hillel · 2021 · The Laryngoscope
  36. A mechanistic modeling framework reveals the key principles underlying tumor metabolism
    Shubham Tripathi, Jun Hyoung Park, Shivanand Pudakalakatti, Pratip K. Bhattacharya, Benny Abraham Kaipparettu, Herbert Levine · 2022 · PLoS Computational Biology
  37. Rethinking our approach to cancer metabolism to deliver patient benefit
    Saverio Tardito, Craig MacKay · 2023 · British Journal of Cancer
  38. Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
    Ichidai Tanaka, Junji Koyama, Hideyuki Itoigawa, Shunsaku Hayai, Masahiro Morise · 2023 · Frontiers in Oncology
  39. ASCT2-mediated glutamine uptake promotes Th1 differentiation via ROS-EGR1-PAC1 pathway in oral lichen planus
    Wei Li, Zihang Ling, Jinmei Wang, Zhangci Su, Jingyi Lu, Xi Yang, Bin Cheng, Xiaoan Tao · 2023 · Biochemical Pharmacology
  40. Discovery of tert-Butyl Ester Based 6-Diazo-5-oxo- l -norleucine Prodrugs for Enhanced Metabolic Stability and Tumor Delivery
    Kateřina Novotná, Lukáš Tenora, Eva Prchalová, James Paule, Jesse Alt, Vijayabhaskar Veeravalli, Jenny Lam, Ying Wu, Ivan Šnajdr, Sadakatali S. Gori et al. · 2023 · Journal of Medicinal Chemistry
  41. Glutaminolysis of CD4+ T Cells: A Potential Therapeutic Target in Viral Diseases
    Yushan Xu, Miaomiao Li, Mengjiao Lin, Dawei Cui, Jue Xie · 2024 · Journal of Inflammation Research
  42. Reprogramming T-cell metabolism to enhance adoptive cell therapies
    Meghan Kates, Samuel David Saibil · 2024 · International Immunology
  43. Therapeutic resurgence of 6-diazo-5-oxo-l-norleucine (DON) through tissue-targeted prodrugs
    Kateřina Novotná, Lukáš Tenora, Barbara Stauch Slusher, Rana Rais · 2024 · Advances in pharmacology
  44. Targeting cellular adaptive responses to glutaminolysis perturbation for cancer therapy
    Minjoong Kim, Sunsook Hwang, Seung Min Jeong · 2024 · Molecules and Cells
  45. Integrated machine learning screened glutamine metabolism-associated biomarker SLC1A5 to predict immunotherapy response in hepatocellular carcinoma
    Guixiong Zhang, Yitai Xiao, Hang Liu, Yanqin Wu, Miao Xue, Jiaping Li · 2024 · Immunobiology
  46. Metabolic Reprogramming of Cancer-Associated Fibroblast in the Tumor Microenvironment: From Basics to Clinic
    Lujia Zhou, Wenjie Zhang, Xiaoxue Hu, Daorong Wang, Dong Tang · 2024 · Clinical Medicine Insights Oncology
  47. Scutellarein inhibits lung cancer growth by inducing cell apoptosis and inhibiting glutamine metabolic pathway
    Di Zhang, Yinwen Wang, Peng Yu, Jiayi Sun, Jingyang Li, Yingfan Hu, Xianli Meng, Juan Li, Xiang Li · 2024 · Journal of Ethnopharmacology
  48. Landscape of targeted therapies for lung squamous cell carcinoma
    Qiuxuan Chen, Xiao-Shuo Zheng, Weiting Cheng, Jian Li · 2024 · Frontiers in Oncology
  49. Real-time ROS monitoring-guided tumor electrodynamic therapy using a metal microneedle array system
    Xiaoxue Xie, Jing Liu, Jing Liu, Huiye Wei, Minzhao Lin, Gengjia Chen, Zhibo Liu, Mengyi He, Xinshuo Huang, Shuang Huang et al. · 2025 · Nano Today
  50. Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer
    Stephen Yiu Chuen Choi, Caroline F. Ribeiro, Yuzhuo Z. Wang, Massimo F. Loda, Stephen R. Plymate, Takuma Uo · 2022 · Biomolecules
  51. Overcoming current challenges to T-cell receptor therapy via metabolic targeting to increase antitumor efficacy, durability, and tolerability
    Wendy Mao · 2022 · Frontiers in Immunology
  52. Metabolomic and Transcriptomic Changes Underlying the Effects of L-Citrulline Supplementation on Ram Semen Quality
    Guodong Zhao, Xi Zhao, Jiachen Bai, Airixiati Dilixiati, Yukun Song, Aerman Haire, Shangshang Zhao, Aikebaier Aihemaiti, Xiangwei Fu, Abulizi Wusiman · 2023 · Animals
  53. Breast cancers as ecosystems: a metabolic perspective
    Flavia Martino, Mariadomenica Lupi, Enrico Giraudo, Letizia Lanzetti · 2023 · Cellular and Molecular Life Sciences
  54. The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis
    Kui Liu, Jing Ma, Jiao Ao, Lili Mu, Yixian Wang, Yue Qian, Xue Jin, Wei Zhang · 2021 · Journal of Oncology
  55. Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in Inflammation
    Ayaka Sugiura, Katherine L. Beier, Channing Chi, Darren R. Heintzman, Xiang Ye, Melissa M. Wolf, Andrew R. Patterson, Jacqueline-Yvonne Cephus, Hanna S. Hong, Costas Andreas Lyssiotis et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Targeting Glutamine Metabolism Transporter SLC25A22 Enhances CD8+ T‐Cell Function and Anti‐PD‐1 Therapy Efficacy in Cervical Squamous Cell Carcinoma: Integrated Metabolomics, Transcriptomics and T‐Cell‐Incorporated Tumor Organoid Studies
    Tingting Ren, Junjun Qiu, Fanghua Chen, Qian Jiang, Qinqin Liu, Tong Wu, Hua Jiang, Keqin Hua · 2025 · Advanced Science
  57. Mechano‐Iontronic Hydrogels Generating Biomimetic Endogenous Bioelectricity for Promoting Cartilage Regeneration
    Longwei Li, Zheng Li, Muxin Yue, Yangshi Shao, Jing Wang, Yutong Song, Zhong Lin Wang, Yongsheng Zhou, Xiong Pu · 2025 · Advanced Materials
  58. Hypoxic microenvironment in cancer: role in metabolic reprogramming
    Sureka, Niti, Maheshwari, Rashi, Agravat, Amit, Singhal, Shweta, Zaman, Shamsuz, Rishi, Bhavika, Siraj, Fouzia, Zaheer, Sufian, Misra, Aroonima · 2026 · Frontiers in Oncology
  59. The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma
    Jianbo Wu, Fuqing Meng, Danyang Ran, Yalong Song, Yunkun Dang, Fan Lai, Longyan Yang, Mi Deng, Yuqin Song, Jun Zhu · 2023 · Metabolites
  60. Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
    Qiuyue Zhang, Jinchen Liu, Haifeng Lin, Bo Lin, Mingyue Zhu, Mengsen Li · 2023 · Exploration of Targeted Anti-tumor Therapy
  61. System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma
    Bolin Wang, Jinli Pei, Shengnan Xu, Jie Liu, Jinming Yu · 2023 · Computers in Biology and Medicine
  62. Azo-based hypoxic-activated 6-diazo-5-oxo-L-norleucine (DON) prodrug combined with vascular disrupting agent nanoparticles for tumor-selective glutamine metabolism blockade
    Hang Xu, Mengfei Zheng, Chenguang Yang, Kun Wang, Zheng Lv, Zhilin Liu, Zhaohui Tang, Xuesi Chen · 2023 · Chemical Engineering Journal
  63. Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment
    Hua Cheng, Yongbin Zheng · 2024 · PeerJ
  64. Aerobic glycolysis but not GLS1-dependent glutamine metabolism is critical for anti-tumor immunity and response to checkpoint inhibition
    Patrick M. Gubser, Sharanya K M Wijesinghe, Leonie Heyden, Sarah S. Gabriel, David Peter De Souza, Christoph Hess, Malcolm M McConville, Daniel T. Utzschneider, Axel Kallies · 2024 · Cell Reports
  65. Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models
    Daan F. Boreel, Anne P.M. Beerkens, Sandra Heskamp, Milou Boswinkel, Johannes P. W. Peters, Gosse J. Adema, Paul N. Span, Johan Bussink · 2024 · Clinical and Translational Radiation Oncology
  66. Metabolism: an important player in glioma survival and development
    Ning Wang, Yiru Yuan, Tianhao Hu, Huizhe Xu, Haozhe Piao · 2024 · Discover Oncology
  67. Pyrimidine synthesis enzyme CTP synthetase 1 suppresses antiviral interferon induction by deamidating IRF3
    Youliang Rao, Chao Qin, Ali Can Savas, Qizhi Liu, Shu Feng, Guoli Hou, Taolin Xie, Pinghui Feng · 2024 · Immunity
  68. Lipids guide T cell antitumor immunity by shaping their metabolic and functional fitness
    Letizia Rumiano, Teresa Manzo · 2024 · Trends in Endocrinology and Metabolism
  69. Radiotherapy-induced alterations in tumor microenvironment: metabolism and immunity
    Jinpeng Chen, Sheng Wang, Yue Ding, XU Duo, Shiya Zheng · 2025 · Frontiers in Cell and Developmental Biology
  70. CD8 agonism functionally activates memory T cells and enhances antitumor immunity
    Alaa Madi, Nina Weisshaar, Michael Buettner, Gernot Poschet, Sicong Ma, Jingxia Wu, Alessa Mieg, Marvin Hering, Yanan Ming, Kerstin Möhr et al. · 2022 · International Journal of Cancer
  71. The Role of Amino Acid Metabolic Reprogramming in Tumor Development and Immunotherapy
    Safir Ullah Khan, Munir Ullah Khan · 2022 · Biochemistry and Molecular Biology
  72. Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies
    Xintong Peng, Jingfan Zheng, Tianzi Liu, Ziwen Zhou, Song Chen, Yan Geng, Zichuan Wang, Yan Huang · 2023 · Current Cancer Drug Targets
  73. Enzymatic depletion of circulating glutamine is immunosuppressive in cancers
    Monish Kumar, Ankita Leekha, Suman Nandy, Rohan SUDHIR Kulkarni, Melisa A. Martinez-Paniagua, K M Samiur Rahman Sefat, Richard C. Willson, Navin Varadarajan · 2024 · iScience
  74. Metabolic and OXPHOS Activities Quantified by Temporal ex vivo Analysis Display Patient-Specific Metabolic Vulnerabilities in Human Breast Cancers
    Andre Koit, Natalja Timohhina, Laura Truu, Vladimir A. Chekulayev, Shivakumar Gudlawar, Igor N. Shevchuk, Katrin Lepik, Léa Mallo, Riina Kütner, Vahur Valvere et al. · 2020 · Frontiers in Oncology
  75. Metabolic reprogramming and cancer precision medicine: a narrative review
    Hong Zhang, Shuang Tang · 2021 · Precision Cancer Medicine
  76. Metabolic cross-talk between ovarian cancer and the tumor microenvironment—providing potential targets for cancer therapy
    Yi Lin, Xiao Liang, Xijie Zhang, Yanghong Ni, Xiaoting Zhou, Xia Zhao · 2022 · Frontiers in Bioscience-Landmark
  77. Immunological Tolerance
    Pooya Farhangnia, Mahzad Akbarpour · 2021 · Elsevier eBooks
  78. Cancer suppresses mitochondrial chaperone activity in macrophages to drive immune evasion
    Haoxin Zhao, Jaeoh Park, Yuzhu Wang, Yi-Ju Chou, Lemin Li, Lydia N. Raines, Michael Hsu, Ching-Cheng Lin, Wei Cao, Yuli Ouyang et al. · 2025 · Nature Immunology
  79. Intracellular spatiotemporal metabolism in connection to target engagement
    Jingwei Zhang, Zhixia Qiu, Yongjie Jessica Zhang, Guangji Wang, Haiping Hao · 2023 · Advanced Drug Delivery Reviews
  80. The Role and Treatment Strategies of Ammonia-Related Metabolism in Tumor Microenvironment
    Qizhen Ye, Dan Li, Yi Zou, Ying Yuan · 2024 · Current Gene Therapy
  81. Endoplasmic Reticulum Stress Potentiates the Immunosuppressive Microenvironment in Hepatocellular Carcinoma by Promoting the Release of SNHG6-Enriched Small Extracellular Vesicles
    Chengdong Liu, Xiaohan Zhou, Hanyi Zeng, Jiaping Yu, Wenwen Li, Wanli Zhang, Yanxia Liao, Haijian Wang, Li Liu · 2024 · Cancer Immunology Research
  82. GlutaR: A High‐Performance Fluorescent Protein‐Based Sensor for Spatiotemporal Monitoring of Glutamine Dynamics In Vivo
    Bingjie Liu, Zijie Zhao, Pengcheng Wang, Kamiran Aihemaiti, Lixin Zhu, Qingpeng Wei, Wenzhe Li, Xia Yuan, Jing Wu, Changtao Jiang et al. · 2024 · Angewandte Chemie International Edition
  83. Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib‐Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency
    Jiali Huang, Xiankang Zhang, Hui Zhang, Yu Li, Huidan Huang, Zhiyu Li, Zhixia Qiu, Hongxi Wu, Dechun Huang, Xi Jin Xu et al. · 2024 · Advanced Science
  84. Metabolic Singularities in Microsatellite-Stable Colorectal Cancer: Identifying Key Players in Immunosuppression to Improve the Immunotherapy Response
    Teresa Gorría, Marina Sierra-Boada, Mariam Rojas, Carolina Figueras, Silvia Marín, Sergio Madurga, Marta Cascante, Joan Maurel · 2025 · Cancers
  85. Model systems to study Mycobacterium tuberculosis infections: an overview of scientific potential and impediments
    Prachi Nangpal, Neha Nagpal, Nupur Angrish, Garima Khare · 2025 · Frontiers in Cellular and Infection Microbiology
  86. Computational modeling of cancer cell metabolism along the catabolic-anabolic axes
    Javier Villela Castrejon, Herbert Levine, Benny Abraham Kaipparettu, José N. Onuchic, Jason Thomas George, Dongya Jia · 2025 · npj Systems Biology and Applications
  87. Recent advances and challenges of cellular immunotherapies in lung cancer treatment
    Chengfei Yang, Yue Liu, Ziqi Huang, Sijin Liu, Xi Zhang, Quanxing Liu, Jigang Dai · 2025 · Experimental Hematology and Oncology
  88. Glutamine synthetase shields triple-negative breast cancer cells from ferroptosis in metastasis triggered by glutamine deprivation
    Zhaoting Yang, Xinyu Lian, Yuan Ming Luo, Qiao Ye, Guangjin Guo, Guoquan Liu · 2025 · Breast Cancer Research
  89. CpG-ODN induced antimicrobial immunity in neonatal chicks involves a substantial shift in serum metabolic profiles
    Kalhari Bandara Goonewardene, Naama Karu, Khawaja Ashfaque Ahmed, Shelly Popowich, Betty Chow-Lockerbie, Lisanework E. Ayalew, Ruwani Karunarathna, Thushari Gunawardana, Mengying Liu, Suresh Kumar Tikoo et al. · 2021 · Scientific Reports
  90. Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy
    Zhengshuo Li, Xiaoyue Zhang, Can Liu, Jian Ma · 2021 · Frontiers in Cell and Developmental Biology
  91. Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review
    Shreya Budhiraja, Hinda Najem, Shashwat Tripathi, Nitin R. Wadhawani, Craig Horbinski, Matthew McCord, Alicia C. Lenzen, Amy B. Heimberger, Michael G. DeCuypere · 2023 · Cancers
  92. Insights into the tumor-stromal-immune cell metabolism cross talk in ovarian cancer
    Priscilla W. Tang, Leonard G. Frisbie, Nadine Hempel, Lan Gardner Coffman · 2023 · American Journal of Physiology-Cell Physiology
  93. Discovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast Cancer
    Ran Luo, Haoyi Zhao, Siqi Deng, Jiale Wu, Haijun Wang, Xiaoshan Guo, Cuicui Han, Wenkang Ren, Yinglong Han, Jianwen Zhou et al. · 2024 · Molecules
  94. Mechanisms and strategies to overcome immunotherapy resistance in hepatobiliary malignancies
    Jia Xiong, Qingqing Wang · 2022 · Hepatobiliary & pancreatic diseases international
  95. Design, synthesis, and pharmacological evaluation of 2-(1-(1,3,4-thiadiazol-2-yl)piperidin-4-yl)ethan-1-ol analogs as novel glutaminase 1 inhibitors
    Tao Yang, Yang Tian, Yingxue Yang, Minghai Tang, Mingsong Shi, Yong Xia Chen, Zhuang Yang, Lijuan Chen · 2022 · European Journal of Medicinal Chemistry
  96. Cancer chemoprevention with PV-1, a novel Prunella vulgaris-containing herbal mixture that remodels the tumor immune microenvironment in mice
    Qi Zhang, Xu Chen, Katie A. Palen, Bryon D. Johnson, Dinh Bui, Donghai Xiong, Jing Pan, Ming Hu, Yian Wang, Ming You · 2023 · Frontiers in Immunology
  97. The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy
    Yanyan Zhang, Jingxin Zhang, Shijie Shang, Jiachun Ma, Fei Wang, Meng Wu, Jinming Yu, Dawei Chen · 2024 · Frontiers in Oncology
  98. Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance
    Ting Mei, Ting Ye, Dingkun Huang, Yuxiu Xie, Ying Xue, Dongfang Zhou, Weimin Wang, Jing Chen · 2024 · Cellular Oncology
  99. Zero-Crosstalk Tumor-Targeting Ratiometric Near-Infrared γ-Glutamyltranspeptidase Probe for Fluorescent-Guided Surgical Resection of Orthotopic Hepatic Tumor
    Zhichao Yang, ZhiHao Yang, Zhi-Qing Wang, Yao Li, Guojiang Mao, Liufang Hu, Juan Ouyang, Chunyan Li · 2025 · Analytical Chemistry
  100. Tumor Microenvironment: Obstacles and Opportunities for T Cell–Based Tumor Immunotherapies
    Mei Hu, Ying Zhao, Nan Zhang, Fang‐Yuan Gong, Wei Zhang, Chunsheng Dong, Jianfeng Dai, Jun Wang · 2025 · Molecular Cancer Research